Today, I had the chance take part in a Google+ Hangout organized by TEDMED. A part of TEDMED’s Great Challenges series, the Hangout, titled, “A Delicate Balance: How Can We Rightsize Treatment Costs,?” was a lively discussion among stakeholders from across the health care ecosystem, including:
- Vineet Arora, Director of Education Initiatives, Costs of Care, Associate Program Director for the Internal Medicine Residency and Assistant Dean of Scholarship & Discovery, University of Chicago
- James Chambers, Assistant Professor of Medicine, the Tufts Medical Center Institute for Clinical Research and Health Policy Studies
- Greg Gierer, Vice President of Policy, America’s Health Insurance Plans
- Josh Fangmeier, Policy Analyst at Center for Healthcare Research & Transformation (CHRT), University of Michigan
The constructive dialogue was moderated by The New York Times’ Elisabeth Rosenthal and was a chance for a diverse group to convene and focus on not only our great challenges, but also on our creative solutions.
I invite you to watch the hangout and join the conversation.
Randy Burkholder Randy Burkholder is Vice President of Policy and Research at PhRMA. He has over 17 years experience in health care policy, advocacy and communications in the medical technology and pharmaceutical industries.
Topics: Drug Cost